Myris Therapeutics
Biotechnology Research • 
307 23rd Street Ext, Suite 150, United States • 21-50 Employees
Company overview
| Headquarters | 307 23rd Street Ext, Suite 150, Pittsburgh, Pennsylvania 15215, US |
| Websites | |
| Keywords | Biotechnology And Protein Conjugation |
| Founded | 2016 |
| Employees | 21-50 |
Key Contacts at Myris Therapeutics
Laura E. Benjamin
Ceo And President, Myris Therapeutics
Matthew Cummings
Sr. Director, Analytical Sciences
Myris Therapeutics Email Formats
Myris Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biohybridsolutions.com), used 52.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@biohybridsolutions.com | 52.6% |
{first name}.{last name} | john.doe@biohybridsolutions.com | 26.3% |
{first name} | john@myristx.com | 10.5% |
{last name}{last name} | doedoe@myristx.com | 10.5% |
About Myris Therapeutics
Myris Therapeutics is a biotechnology company developing ultra-high DAR ADCs by integrating traditional ADC engineering with next-generation polymer chemistry.
$
Myris Therapeutics revenue & valuation
| Annual revenue | $2,138,875 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,900,000 |
| Total funding | $200,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Entry
Manager
Senior
Employees by Department
Myris Therapeutics has 6 employees across 3 departments.
Departments
Number of employees
Australia
United Kingdom
South Africa
PortugalFrequently asked questions
Myris Therapeutics is located in 307 23rd Street Ext, Suite 150, US.
Myris Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.
Myris Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
Myris Therapeutics has raised a total of $200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
